Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis
Open Access
- 27 December 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 47 (1), 153-159
- https://doi.org/10.1002/hep.21941
Abstract
Current guidelines recommend esophagogastroduodenoscopy (EGD) in patients with cirrhosis to screen for gastroesophageal varices (GEV). Thrombocytopenia has been proposed as a noninvasive test to predict the presence of GEV. There is no agreement regarding a specific platelet count (PLT) that can reliably predict GEV. The present longitudinal study aims to (1) further investigate the relationship between varices and PLT at the time of endoscopy, (2) investigate whether changes in PLT from the baseline over time can predict the development of GEV, and (3) investigate whether changes in PLT correlate with the hepatic venous pressure gradient (HVPG). A secondary analysis was conducted for 213 subjects with compensated cirrhosis with portal hypertension but without GEV enrolled in a randomized, placebo-controlled, double-blind trial of a nonselective beta-blocker used to prevent GEV. PLTs were obtained every 3 months, and HVPG measurements and EGD were done annually. The PLTs were compared between subjects who did and did not develop GEV. In a median follow-up of 54.9 months, 84 patients developed GEV. PLT was greater than 150,000 in 15% of patients at the development of GEV. A receiver operating curve did not show any PLT with high sensitivity or specificity for the presence of GEV. Subjects with clinically insignificant portal hypertension (HVPG < 10 mm Hg) whose PLT remained greater than 100,000 had a 2-fold reduction in the occurrence of GEV ( P = 0.0374). A significant correlation was found between HVPG and PLT at the baseline, year 1, and year 5 ( P < 0.0001). Conclusion: Cross-sectional or longitudinal evaluations of PLTs are inadequate noninvasive markers for GEV. Patients with mild portal hypertension whose PLT remains greater than 100,000 have significantly less risk of GEV. Although HVPG correlates somewhat with PLT, changes in PLT cannot be used as a surrogate for HVPG changes. (Hepatology 2008;47:153–159.)Keywords
This publication has 23 references indexed in Scilit:
- The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosisGastrointestinal Endoscopy, 2006
- ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005Gastrointestinal Endoscopy, 2005
- Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertensionJournal of Hepatology, 2005
- Correlação entre a contagem de plaquetas no sangue e o gradiente de pressão venosa hepática em pacientes cirróticosArquivos de Gastroenterologia, 2005
- The hepatic venous pressure gradient: Anything worth doing should be done rightHepatology, 2004
- Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitisHepatology, 2004
- Noninvasive markers of esophageal varices: Another round, not the last†Hepatology, 2004
- The incidence of esophageal varices in cirrhosisGastroenterology, 2001
- HypersplenismEuropean Journal of Gastroenterology & Hepatology, 2001
- Portal hypertension and variceal bleeding: An AASLD single topic symposium†Hepatology, 1998